Search research articles
Contact Us
Filters
Showing results (271-280 of 415) with videos related to
Page
of 42
Sort By:
Plos One
|
June 22, 2012
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Alexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, et al.
Open Forum Infectious Diseases
|
November 7, 2024
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial
Annalisa Marinosci, Delphine Sculier, Gilles Wandeler, et al.
Sexually Transmitted Infections
|
December 10, 2023
Multicentric evaluation of a specific intrathecal anti-<i>Treponema pallidum</i> IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case-control study
Chloé Alberto, Nathalie Lambeng, Christine Deffert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 13, 2022
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study
Isabella C Schoepf, Christian W Thorball, Helen Kovari, et al.
Eclinicalmedicine
|
December 9, 2020
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis
Steve Kanters, Marco Vitoria, Michael Zoratti, et al.
The Lancet. HIV
|
August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
Steve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.
Antiviral Therapy
|
November 18, 2009
Safety and efficacy of once-daily nevirapine dosing: a multicohort study
Alexandra Calmy, Nathalie Vallier, Alain Nguyen, et al.
Plos One
|
September 17, 2013
Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field
Cristina Granziera, Alessandro Daducci, Samanta Simioni, et al.
Open Forum Infectious Diseases
|
August 5, 2024
Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
Léna Royston, Aude Jary, Carolina A Berini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2023
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data
Mattia Berton, Sara Bettonte, Felix Stader, et al.
Page
of 42
Search research articles
Search
Showing results (271-280 of 415) with videos related to
Sort By:
Page
of 42
Plos One
|
June 22, 2012
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Alexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, et al.
Open Forum Infectious Diseases
|
November 7, 2024
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial
Annalisa Marinosci, Delphine Sculier, Gilles Wandeler, et al.
Sexually Transmitted Infections
|
December 10, 2023
Multicentric evaluation of a specific intrathecal anti-<i>Treponema pallidum</i> IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case-control study
Chloé Alberto, Nathalie Lambeng, Christine Deffert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 13, 2022
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study
Isabella C Schoepf, Christian W Thorball, Helen Kovari, et al.
Eclinicalmedicine
|
December 9, 2020
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis
Steve Kanters, Marco Vitoria, Michael Zoratti, et al.
The Lancet. HIV
|
August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
Steve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.
Antiviral Therapy
|
November 18, 2009
Safety and efficacy of once-daily nevirapine dosing: a multicohort study
Alexandra Calmy, Nathalie Vallier, Alain Nguyen, et al.
Plos One
|
September 17, 2013
Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field
Cristina Granziera, Alessandro Daducci, Samanta Simioni, et al.
Open Forum Infectious Diseases
|
August 5, 2024
Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
Léna Royston, Aude Jary, Carolina A Berini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2023
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data
Mattia Berton, Sara Bettonte, Felix Stader, et al.
Page
of 42